Postbiotic Metabolites from a 31-Strain

Shuhei Ueda, Takumi Iwasawa, Kaho Ohki, Satoshi Takeda, Ryohma Tsuchiya, Shunsuke Sakuraba, Kazunori Kato, Tomoaki Ito

Abstract read

In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Protective Effects ofFoods (Basel, Switzerland) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuhei UedaDepartment of Surgery, Juntendo University Shizuoka Hospital, School of Medicine, Juntendo University, Shizuoka 410-2295, Japan.

Takumi IwasawaShizuoka Medical Research Center for Disaster, Juntendo University, Shizuoka 410-2295, Japan.ORCID 0009-0008-9278-6464

Kaho OhkiDepartment of Nutrition Sciences, Graduate School of Health and Sports Sciences, Toyo University, Tokyo 115-8650, Japan.

Satoshi TakedaShizuoka Medical Research Center for Disaster, Juntendo University, Shizuoka 410-2295, Japan.

Ryohma TsuchiyaShizuoka Medical Research Center for Disaster, Juntendo University, Shizuoka 410-2295, Japan.

Shunsuke SakurabaDepartment of Surgery, Juntendo University Shizuoka Hospital, School of Medicine, Juntendo University, Shizuoka 410-2295, Japan.

Kazunori KatoInstitute of Life Innovation Studies, Toyo University, Tokyo 115-8650, Japan.

Tomoaki ItoDepartment of Surgery, Juntendo University Shizuoka Hospital, School of Medicine, Juntendo University, Shizuoka 410-2295, Japan.ORCID 0000-0003-4190-8923

Funding

Grant-in-Aid for Special Research in Subsidies for ordinary expenses of private schools from The Promotion and Mutual Aid Corporation for Private Schools of Japan. noneResearch funding from SOPHIA Co., Ltd. none

6 · The paper itself

Abstract

Postbiotics produced by beneficial bacteria are emerging as safe dietary approaches to intestinal inflammation. We evaluated intestinal bacterial metabolites (IBM), a cell-free fermented soybean extract generated by co-culturing 31

Indexed as

cytokinesDSS colitisgut microbiotaintestinal bacterial metabolites (IBM)intestinal barrierpostbiotics

Identifiers

PMID41823856

DOI10.3390/biology15050428

PMCPMC12985329

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.